Ongoing microstructural changes in the cervical cord underpin disability progression in early primary progressive multiple sclerosis

Abstract

Background:

Pathology in the spinal cord of patients with primary progressive multiple sclerosis (PPMS) contributes to disability progression. We previously reported abnormal Q-space imaging (QSI)-derived indices in the spinal cord at baseline in patients with early PPMS, suggesting early neurodegeneration.

Objective:

The aim was to investigate whether changes in spinal cord QSI over 3 years in the same cohort are associated with disability progression and if baseline QSI metrics predict clinical outcome.

Methods:

Twenty-three PPMS patients and 23 healthy controls recruited at baseline were invited for follow-up cervical cord 3T magnetic resonance imaging (MRI) and clinical assessment after 1 year and 3 years. Cord cross-sectional area (CSA) and QSI measures were obtained, together with standard brain MRI measures. Mixed-effect models assessed MRI changes over time and their association with clinical changes. Linear regression identified baseline MRI indices associated with disability at 3 years.

Results:

Over time, patients deteriorated clinically and showed an increase in cord QSI indices of perpendicular diffusivity that was associated with disability worsening, independently of the decrease in CSA. Higher perpendicular diffusivity and lower CSA at baseline predicted worse disability at 3 years.

Conclusion:

Increasing spinal cord perpendicular diffusivity may indicate ongoing neurodegeneration, which underpins disability progression in PPMS, independently of the development of spinal cord atrophy.

Keywords

Multiple sclerosis spinal cord magnetic resonance imaging progressive diffusion

Get full access to this article

View all access options for this article.

References

Khaleeli

Ciccarelli

Manfredonia

, et al. Predicting progression in primary progressive multiple sclerosis: A 10-year multicenter study. Ann Neurol 2008; 63(6): 790–793.

Confavreux

Vukusic

Adeleine

Early clinical predictors and progression of irreversible disability in multiple sclerosis: An amnesic process. Brain 2003; 126(Pt. 4): 770–782.

Ciccarelli

Cohen

Reingold

, et al. Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disorders. Lancet Neurol 2019; 18(2): 185–197.

Cohen

Assaf

High b-value q-space analyzed diffusion-weighted MRS and MRI in neuronal tissues: A technical review. NMR Biomed 2002; 15(7–8): 516–542.

Assaf

Ben-Bashat

Chapman

, et al. High b-value q-space analyzed diffusion-weighted MRI: Application to multiple sclerosis. Magn Reson Med 2002; 47(1): 115–126.

Farrell

JAD

Smith

Gordon-Lipkin

, et al. High b-value q-space diffusion-weighted MRI of the human cervical spinal cord in vivo: Feasibility and application to multiple sclerosis. Magn Reson Med 2008; 59(5): 1079–1089.

Abdel-Aziz

Schneider

Solanky

, et al. Evidence for early neurodegeneration in the cervical cord of patients with primary progressive multiple sclerosis. Brain 2015; 138(Pt. 6): 1568–1582.

Thompson

Banwell

Barkhof

, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 2018; 17: 162–173.

Cawley

Tur

Prados

, et al. Spinal cord atrophy as a primary outcome measure in phase II trials of progressive multiple sclerosis. Mult Scler 2018; 24(7): 932–941.

10.

Kurtzke

JF.

Rating neurologic impairment in multiple sclerosis: An Expanded Disability Status Scale (EDSS). Neurology 1983; 33(11): 1444–1452.

11.

Goodkin

Hertsgaard

Seminary

Upper extremity function in multiple sclerosis: Improving assessment sensitivity with box-and-block and nine-hole peg tests. Arch Phys Med Rehabil 1988; 69(10): 850–854.

12.

Cutter

Baier

Rudick

, et al. Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Brain 1999; 122(Pt. 5): 871–882.

13.

Deeba

Koptides

Gaglia

, et al. Evaluation of Epstein-Barr virus-specific antibodies in Cypriot multiple sclerosis patients. Mol Immunol 2018; 105: 270–275.

14.

Marino

Ditunno

Jr Donovan

, et al. Neurologic recovery after traumatic spinal cord injury: Data from the model spinal cord injury systems. Arch Phys Med Rehabil 1999; 80(11): 1391–1396.

15.

Hobart

Riazi

Lamping

, et al. Measuring the impact of MS on walking ability: The 12-Item MS Walking Scale (MSWS-12). Neurology 2003; 60(1): 31–36.

16.

Bohannon

Smith

MB.

Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther 1987; 67: 206–207.

17.

Bunn

Marsden

Giunti

, et al. Stance instability in spinocerebellar ataxia type 6. Mov Disord 2013; 28(4): 510–516.

18.

Yiannakas

Kearney

Samson

, et al. Feasibility of grey matter and white matter segmentation of the upper cervical cord in vivo: A pilot study with application to magnetisation transfer measurements. NeuroImage 2012; 63(3): 1054–1059.

19.

Horsfield

Sala

Neema

, et al. Rapid semi-automatic segmentation of the spinal cord from magnetic resonance images: Application in multiple sclerosis. NeuroImage 2010; 50(2): 446–455.

20.

Prados

Cardoso

Kanber

, et al. A multi-time-point modality-agnostic patch-based method for lesion filling in multiple sclerosis. NeuroImage 2016; 139: 376–384.

21.

Cardoso

Modat

Wolz

, et al. Geodesic information flows: Spatially-variant graphs and their application to segmentation and fusion. IEEE Trans Med Imaging 2015; 34(9): 1976–1988.

22.

Smith

Zhang

Jenkinson

, et al. Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. NeuroImage 2002; 17(1): 479–489.

23.

DeBoy

Zhang

Dike

, et al. High resolution diffusion tensor imaging of axonal damage in focal inflammatory and demyelinating lesions in rat spinal cord. Brain 2007; 130(Pt. 8): 2199–2210.

24.

Budde

Xie

Cross

, et al. Axial diffusivity is the primary correlate of axonal injury in the experimental autoimmune encephalomyelitis spinal cord: A quantitative pixelwise analysis. J Neurosci 2009; 29(9): 2805–2813.

25.

Saidha

Chen

, et al. Spinal cord quantitative MRI discriminates between disability levels in multiple sclerosis. Neurology 2013; 80(6): 540–547.

26.

Moccia

Ruggieri

Ianniello

, et al. Advances in spinal cord imaging in multiple sclerosis. Ther Adv Neurol Disord 2019; 12: 840593.

27.

Tur

Moccia

Barkhof

, et al. Assessing treatment outcomes in multiple sclerosis trials and in the clinical setting. Nat Rev Neurol 2018; 14(2): 75–93.

28.

Singhal

Tauhid

Hurwitz

, et al. The effect of glatiramer acetate on spinal cord volume in relapsing-remitting multiple sclerosis. J Neuroimaging 2017; 27(1): 33–36.

29.

Miller

Lublin

Sormani

, et al. Brain atrophy and disability worsening in primary progressive multiple sclerosis: Insights from the INFORMS study. Ann Clin Transl Neurol 2018; 5(3): 346–356.

30.

Tsagkas

Magon

Gaetano

, et al. Preferential spinal cord volume loss in primary progressive multiple sclerosis. Mult Scler 2019; 25; 947–957.

31.

Aymerich

Auger

Alonso

, et al. Cervical cord atrophy and long-term disease progression in patients with primary-progressive multiple sclerosis. AJNR Am J Neuroradiol 2018; 39(2): 399–404.

32.

Battaglini

Gentile

Luchetti

, et al. Lifespan normative data on rates of brain volume changes. Neurobiol Aging 2019; 81: 30–37.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.32 MB